Soluble and Cellular Immune Responses in MM Patients Receiving Id Vaccines
| UPN . | Anti-KLH . | Anti-Id . | |||
|---|---|---|---|---|---|
| Ab . | Cell . | Ab . | Cell . | DTH . | |
| 14 | Pos | Pos | Neg | Neg | Pos |
| 240 | Pos | Pos | Neg | Neg | Pos |
| 453 | Pos | Neg | Neg | Neg | Pos |
| 485 | Pos | Pos | Neg | Pos | Pos |
| 510 | Pos | Pos | Neg | Neg | Pos |
| 522 | Pos | Pos | Neg | Neg | Pos |
| 535 | Pos | Pos | Neg | Neg | Neg |
| 637 | Pos | ND | Neg | ND | Pos |
| 734 | Pos | Pos | Neg | Pos | Pos |
| 743 | Pos | Neg | Neg | Neg | ND |
| 749 | Pos | Pos | Neg | Neg | ND |
| 874 | Pos | Pos | Neg | Neg | Neg |
| Total immune responses | 12/12 | 9/11 | 0/12 | 2/11 | 8/10 |
| UPN . | Anti-KLH . | Anti-Id . | |||
|---|---|---|---|---|---|
| Ab . | Cell . | Ab . | Cell . | DTH . | |
| 14 | Pos | Pos | Neg | Neg | Pos |
| 240 | Pos | Pos | Neg | Neg | Pos |
| 453 | Pos | Neg | Neg | Neg | Pos |
| 485 | Pos | Pos | Neg | Pos | Pos |
| 510 | Pos | Pos | Neg | Neg | Pos |
| 522 | Pos | Pos | Neg | Neg | Pos |
| 535 | Pos | Pos | Neg | Neg | Neg |
| 637 | Pos | ND | Neg | ND | Pos |
| 734 | Pos | Pos | Neg | Pos | Pos |
| 743 | Pos | Neg | Neg | Neg | ND |
| 749 | Pos | Pos | Neg | Neg | ND |
| 874 | Pos | Pos | Neg | Neg | Neg |
| Total immune responses | 12/12 | 9/11 | 0/12 | 2/11 | 8/10 |
Abbreviations: Ab, soluble antibodies determined by ELISA; Cell, cellular proliferation determined by 3[H]TdR incorporation.